Filtros de búsqueda

Lista de obras de Young-Suk Lim

Comparison of Long-Term Clinical Outcomes Between Spontaneous and Therapy-Induced HBsAg Seroclearance

artículo científico publicado en 2020

Comparison of risk of hepatocellular carcinoma between tenofovir and entecavir: One direction or no direction

artículo científico publicado en 2019

Cost-effectiveness of antiviral treatment in adult patients with immune-tolerant phase chronic hepatitis B

artículo científico publicado en 2020

Discontinuation of nucleos(t)ide analogues is not associated with a higher risk of HBsAg seroreversion after antiviral-induced HBsAg seroclearance: a nationwide multicentre study

artículo científico publicado en 2020

East Asia expert opinion on treatment initiation for chronic hepatitis B

scientific article published on 20 September 2020

Editorial: hepatitis B DNA thresholds and risk of hepatocellular carcinoma: different number patterns in HBeAg-positive versus HBeAg-negative patients. Authors' reply

artículo científico publicado en 2020

Efficacy and Safety of Besifovir Dipivoxil Maleate Compared With Tenofovir Disoproxil Fumarate in Treatment of Chronic HBV Infection

artículo científico publicado en 2018

Evaluation of transarterial chemoembolization refractoriness in patients with hepatocellular carcinoma

artículo científico publicado en 2020

Expedited Safety Reporting to Sponsors Through the Implementation of an Alert System for Clinical Trial Management at an Academic Medical Center: Retrospective Design Study

artículo científico publicado en 2020

High Level of Medication Adherence Is Required to Lower Mortality in Patients with Chronic Hepatitis B Taking Entecavir: A Nationwide Cohort Study

scientific article published on 13 October 2020

High risk of clinical events in untreated HBeAg-negative chronic hepatitis B patients with high viral load and no significant ALT elevation

artículo científico publicado en 2019

Higher Risk of Hepatocellular Carcinoma in Chronic Hepatitis B vs Chronic Hepatitis C after Achievement of Virologic Response

artículo científico publicado en 2017

Impact of ledipasvir/sofosbuvir on the work productivity of genotype 1 chronic hepatitis C patients in Asia

artículo científico publicado en 2017

Lamivudine: fading into the mists of time.

artículo científico publicado en 2017

Letter: moderate levels of serum hepatitis B virus DNA alone are not associated with increased risk of hepatocellular carcinoma in chronic hepatitis B patients. Authors' reply

scientific article published on 01 August 2020

Letter: risk of developing hepatocellular carcinoma in untreated HBeAg-negative chronic hepatitis B patients with high viral load and no significant ALT elevation. Authors' reply

scientific article published on 01 September 2019

Moderate levels of serum hepatitis B virus DNA are associated with the highest risk of hepatocellular carcinoma in chronic hepatitis B patients

scientific article published on 14 April 2020

Monotherapy with tenofovir disoproxil fumarate for adefovir-resistant vs. entecavir-resistant chronic hepatitis B: A 5-year clinical trial

artículo científico publicado en 2019

Proteome Multimarker Panel With Multiple Reaction Monitoring-Mass Spectrometry for Early Detection of Hepatocellular Carcinoma

scientific article published on 13 March 2020

Regorafenib Versus Nivolumab After Sorafenib Failure: Real-World Data in Patients With Hepatocellular Carcinoma

artículo científico publicado en 2020

Response to letter of HEP-20-1282.R1

artículo científico publicado en 2020

Response to letter of HEP-20-2170.R1

scientific article published on 05 October 2020

Risk prediction for patients with hepatocellular carcinoma undergoing chemoembolization: development of a prediction model

artículo científico publicado en 2015

Sofosbuvir and ledipasvir are associated with high sustained virologic response and improvement of health-related quality of life in East Asian patients with hepatitis C virus infection

scholarly article by Zobair M. Younossi published in July 2018

Subclassification of advanced-stage hepatocellular carcinoma with macrovascular invasion: combined transarterial chemoembolization and radiotherapy as an alternative first-line treatment

artículo científico publicado en 2023

Sustained efficacy of adjuvant immunotherapy with cytokine-induced killer cells for hepatocellular carcinoma: an extended 5-year follow-up

artículo científico publicado en 2018

Systematic review with meta-analysis: extrahepatic manifestations in chronic hepatitis C virus-infected patients in East Asia

artículo científico publicado en 2019

Tenofovir disoproxil fumarate reduces hepatocellular carcinoma, decompensation and death in chronic hepatitis B patients with cirrhosis

scientific article published on 16 September 2019

Tenofovir vs. Entecavir on Recurrence of Hepatitis B Virus-Related Hepatocellular Carcinoma after Surgical Resection

scientific article published on 23 April 2020

The Effect of Interferon-Free Regimens on Health-Related Quality of Life in East Asian Patients with Chronic Hepatitis C.

artículo científico publicado en 2017

The Korean Hepatitis C Virus Care Cascade in a Tertiary Institution: Current Status and Changes in Testing, Link to Care, and Treatment

scientific article published in 2022

Validation of US Liver Imaging Reporting and Data System Version 2017 in Patients at High Risk for Hepatocellular Carcinoma

scientific article published on 18 June 2019

What should medical students know about artificial intelligence in medicine?

artículo científico publicado en 2019

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda